The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Primary results of NRG Oncology / NSABP B-43: Phase III trial comparing concurrent trastuzumab (T) and radiation therapy (RT) with RT alone for women with HER2-positive ductal carcinoma in situ (DCIS) after lumpectomy.
 
Melody A. Cobleigh
Consulting or Advisory Role - Genomic Health; Immunomedics; Puma Biotechnology; Roche/Genentech; Seagen
Research Funding - Genentech/Roche (Inst); Macrogenics (Inst); Radius Health (Inst); Seagen (Inst); Synthon (Inst); Zymeworks (Inst)
Patents, Royalties, Other Intellectual Property - Genomic Health
Travel, Accommodations, Expenses - genentech; Immunomedics; Puma Biotechnology; Seagen (Inst)
 
Stewart J. Anderson
No Relationships to Disclose
 
Kalliopi P. Siziopikou
Honoraria - Ventana Medical Systems
 
Douglas W Arthur
Stock and Other Ownership Interests - Advanced Radiation Therapy
 
Thomas B. Julian
No Relationships to Disclose
 
Rachel Rabinovitch
Research Funding - Prelude Therapeutics (Inst)
 
David S. Parda
No Relationships to Disclose
 
Samantha A. Seaward
No Relationships to Disclose
 
Dennis L. Carter
Employment - Rocky Mountain Cancer Centers
 
Janice A. Lyons
No Relationships to Disclose
 
Melissa S. Dillmon
Stock and Other Ownership Interests - Johnson & Johnson (I)
Consulting or Advisory Role - Puma Biotechnology
 
Gustav Magrinat
No Relationships to Disclose
 
Vivek S Kavadi
Employment - US Oncology Network
 
Allison M. Zibelli
No Relationships to Disclose
 
Lavanya Tiriveedhi
No Relationships to Disclose
 
Matthew L. Hill
Stock and Other Ownership Interests - AstraZeneca; Newlink Genetics
 
Marianne Melnik
No Relationships to Disclose
 
Sushil Beriwal
Leadership - Via Oncology
Honoraria - Varian Medical Systems; Via Oncology
Consulting or Advisory Role - Varian Medical Systems
 
Eleftherios P. Mamounas
Honoraria - Genentech/Roche; Genomic Health
Consulting or Advisory Role - bioTheranostics; Daiichi Sankyo; Genomic Health; Merck; Roche/Genentech
Speakers' Bureau - Genentech/Roche; Genomic Health
Travel, Accommodations, Expenses - Genentech/Roche; Genomic Health
 
Norman Wolmark
No Relationships to Disclose